ADMA Biologics
ADMA
$6.81
Share price
1.04%
Change (1 day)
99.12%
Change (1 year)
Categories
P/S ratio for ADMA Biologics (ADMA)
P/S ratio as of May 2024 (TTM): 6.05
According to ADMA Biologics 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 6.04978. At the end of 2023 the company had a P/S ratio of 3.96.
P/S ratio history for ADMA Biologics from 2013 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 3.96 | -28.89% |
| 2022 | 5.56 | 63.08% |
| 2021 | 3.41 | -21.89% |
| 2020 | 4.37 | -45.98% |
| 2019 | 8.08 | 23.96% |
| 2018 | 6.52 | 2.05% |
| 2017 | 6.39 | 3.27% |
| 2016 | 6.19 | -48.62% |
| 2015 | 12.0 | -31.35% |
| 2014 | 17.5 | -25.74% |
| 2013 | 23.6 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Repligen
RGEN | 14.5 | 140.31% | 🇺🇸 USA |
 Novavax NVAX | 0.9536 | -84.24% | 🇺🇸 USA |
 Cel-Sci
CVM | N/A | N/A | 🇺🇸 USA |